H Robotics

About H Robotics

H Robotics, established in 2018 by CEO Chunbae Lee, develops and distributes robotic rehabilitation solutions for individuals with neurological and musculoskeletal conditions. The company's headquarters are in Incheon, South Korea, with a North American corporation established in 2019 and located in Austin, Texas.

The company’s main product is rebless™, an FDA-registered, robotic therapy device designed for both home and clinical use. This multi-joint device provides therapy for the elbow, wrist, ankle, and knee. Rebless™ features multiple operating modes, including passive, active, active-assisted, and resisted motion, allowing for customized therapy based on the patient's condition. It also offers a data-driven tele-rehab platform where clinicians can remotely prescribe treatments, track patient progress through a mobile app, and conduct virtual appointments.

Another key product is the rebless™ planar, a robotic-assisted device for upper extremity rehabilitation that uses interactive assessments and gamification to improve motor skills, strength, and range of motion. H Robotics' business model focuses on making rehabilitation technology more accessible and affordable compared to competitors, enabling more patients to use the devices at home. The company collaborates with rehabilitation centers and technology providers, such as CareSpace and Harmonic Bionics, to integrate its devices into broader tele-rehab programs. Since its founding, H Robotics has achieved several milestones, including receiving a CES Innovation Award in 2022 and being recognized as a top 50 company for R&D excellence in South Korea in 2023.